Dyadic International has expanded its bio-industrial pipeline with a new proprietary enzyme program focused on advanced cellulose processing, building on the success of its EN3ZYME™ product. This initiative leverages Dyadic's Dapibus™ platform to streamline development and manufacturing, targeting applications like pulp biorefining and nanocellulose production. The move taps into a growing multi-billion-dollar industrial enzyme market driven by demand for cost-effective, eco-friendly alternatives to chemical processes. Dyadic plans to commercialize through product sales, partnerships, and licensing, aiming to diversify revenue and support long-term growth.
Lyft director Janey Whiteside sold 14,220 shares of the company's stock at a price of $17 per share. This transaction reflects a significant insider sale, which investors often watch as a signal of confidence or strategic portfolio management. The sa...
Solana (SOL) is currently trading in a consolidation phase well below its previous highs, indicating a potential accumulation period before a major recovery. Analysts highlight a resistance zone near $100, with SOL possibly dipping into an $80-$100 r...
Microsoft shares trade below analyst targets despite strong AI-driven Azure growth and record revenue. The stock fell 6.2% over the past year while peers Alphabet and Amazon rose significantly. Analysts remain bullish, citing a $678 billion commercia...
In 2026, Vanguard's International High Dividend Yield ETF (VYMI) has outperformed the popular US-focused Vanguard S&P 500 ETF (VOO) and Total Stock Market ETF (VTI), delivering higher returns and dividends without leverage or gimmicks. This reflects ...
NG Energy International Corp. announced a 14% increase in Q2 2026 natural gas and NGL sales to US$10.8 million, with year-to-date sales up 24% year-over-year. Production at the Sinú-9 block approximately doubled since Q2, reaching technical export ca...
